{{refimprove|date=January 2017}}

{{Drugbox|verifiedrevid=Please Provide|IUPAC_name=3,5-dimethyl-2-phenylmorpholine|legal_CA=Unscheduled
|legal_US=Analogue
|legal_US_comment = (possibly, in some states)
|CAS_number=1218345-44-8
|PubChem=43367115|drug_name=3,5-dimethyl-2-phenylmorpholine (PDM-35)
|image=
2-phenyl-3,5-dimethylmorpholine.png|alt=|caption=|MedlinePlus=|licence_EU=|pregnancy_AU=|pregnancy_US=|pregnancy_category=|licence_US=|DrugBank=Please Provide}}'''2-Phenyl-3,5-dimethylmorpholine''' is a drug with [[stimulant]] and [[anorectic]] effects, related to [[phenmetrazine]]. Based on what is known from other phenylmorpholines with similar structure, it likely acts as a [[serotonin reuptake inhibitor]] and may produce [[antidepressant]]-like effects.

== See also ==
* [[3-Fluorophenmetrazine]]
* [[G-130]] (2-Phenyl-5,5-dimethylmorpholine)
* 3,4-[[Phendimetrazine]] (2-Phenyl-3,4-dimethylmorpholine)
* [[2-Phenyl-3,6-dimethylmorpholine|3,6-Phendimetrazine]] (2-Phenyl-3,6-dimethylmorpholine)
* [[Manifaxine]]
* [[Radafaxine]]
* [[G-130]]
* [[Viloxazine]]

[[Category:Anorectics]]
[[Category:Serotonin reuptake inhibitors| ]]
[[Category:Stimulants]]